Growth Metrics

OmniAb (OABI) Current Assets (2021 - 2026)

OmniAb (OABI) reported Current Assets of $65.1 million for Q1 2026, up 21.55% year-over-year from $53.6 million in Q1 2025, and little changed on a QoQ basis from $65.3 million in Q4 2025.

OmniAb (OABI) has 6 years of Current Assets data on file, last reported at $65.1 million in Q1 2026.

  • Quarterly Current Assets rose 21.55% year-over-year to $65.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.1 million (up 21.55% YoY) and the FY2025 annual result came in at $65.3 million, down 4.1% from the prior year.
  • Current Assets was little changed at $65.1 million in Q1 2026 per OABI's latest filing, from $65.3 million in the prior quarter.
  • Across five years, Current Assets topped out at $125.0 million in Q4 2022 and bottomed at $423868.0 in Q3 2022.
  • The 5-year median for Current Assets is $66.6 million (2024), against an average of $67.2 million.
  • The widest annual swing landed in 2022, when Current Assets slumped 65.88%; it then soared 25107.85% in 2023.
  • Tracing OABI's Current Assets over 5 years: stood at $125.0 million in 2022, then retreated by 24.05% to $94.9 million in 2023, then retreated by 28.2% to $68.1 million in 2024, then decreased by 4.1% to $65.3 million in 2025, then fell by 0.33% to $65.1 million in 2026.
  • Per Business Quant, the three latest OABI Current Assets figures stand at $65.1 million (Q1 2026), $65.3 million (Q4 2025), and $66.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 10.37 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 37.31 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.25 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 73.04 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 3.59 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 11.73 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 18.21 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.22 Bn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 65.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 65.13 Mn
Dec 31, 2025 65.34 Mn
Sep 30, 2025 66.35 Mn
Jun 30, 2025 47.62 Mn
Mar 31, 2025 53.58 Mn
Dec 31, 2024 68.14 Mn
Sep 30, 2024 66.61 Mn
Jun 30, 2024 67.30 Mn
Mar 31, 2024 76.72 Mn
Dec 31, 2023 94.90 Mn
Sep 30, 2023 106.85 Mn
Jun 30, 2023 115.94 Mn
Mar 31, 2023 121.08 Mn
Dec 31, 2022 124.95 Mn
Sep 30, 2022 423,868.00
Jun 30, 2022 692,011.00
Mar 31, 2022 1.10 Mn
Dec 31, 2021 22.54 Mn
Sep 30, 2021 1.24 Mn